‘The North American market is demonstrating significant “pent-up...

‘The North American market is demonstrating significant “pent-up demand” for Aeris’ unique products and it is anticipated that upon EPA approval for Aeris Active, the USA will quickly become the lead market for the Company’s products, leveraging Aeris’ outstanding kill-time, extended residual activity and full hospital-grade efficacy in a single application. The Company’s capability to deal with the full spectrum of vectors of contamination with environmentally-friendly product demonstration validated and approval residual properties provides a platform for growth well into the future.’

2021 is going to be so good.